These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome. Orth-Höller D; Würzner R Semin Thromb Hemost; 2014 Jun; 40(4):503-7. PubMed ID: 24799304 [TBL] [Abstract][Full Text] [Related]
5. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection]. Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441 [TBL] [Abstract][Full Text] [Related]
6. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome. Karch H Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654 [TBL] [Abstract][Full Text] [Related]
7. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome]. Allerberger F; Sölder B; Caprioli A; Karch H Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722 [TBL] [Abstract][Full Text] [Related]
8. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543 [TBL] [Abstract][Full Text] [Related]